Catalyst Pharmaceuticals Inc. is a pharmaceutical company located in Coral Gables, Florida. Specializing in the development and commercialization of therapies for rare diseases, Catalyst Pharmaceuticals focuses on delivering specialized treatment options that address unmet medical needs. Situated in the heart of Coral Gables, the company plays a significant role in the local healthcare and biotechnology landscape.
The company’s operations encompass various stages of pharmaceutical development, including research, clinical trials, and regulatory processes. By concentrating on niche therapeutic areas, Catalyst Pharmaceuticals aims to bring innovative solutions to patients who may have limited treatment alternatives. Its presence in Coral Gables supports collaboration with medical professionals and institutions throughout Florida and beyond.
Catalyst Pharmaceuticals is accessible to the community and healthcare providers through its office located at 355 Alhambra Circle, Suite 801. The company maintains a commitment to advancing pharmaceutical science while adhering to industry standards and regulatory requirements. Communication with Catalyst Pharmaceuticals can be established via phone at 844-347-3277, ensuring responsiveness to inquiries related to its products and research efforts.
As a pharmaceutical company rooted in Coral Gables, Catalyst Pharmaceuticals contributes to the broader field of medical innovation by focusing on rare disease therapies. Its activities in research and development reflect the growing importance of specialized pharmaceutical enterprises in addressing complex health challenges within the regional and national healthcare environment.
